{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05819866",
            "orgStudyIdInfo": {
                "id": "MT-3-01"
            },
            "organization": {
                "fullName": "Minoryx Therapeutics, S.L.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy",
            "officialTitle": "A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy",
            "acronym": "CALYX",
            "therapeuticArea": [
                "Other"
            ],
            "study": "a-clinical-study-to-assess-the-efficacy-and-safety-of-leriglitazone-in-adult-male-subjects-with-cerebral-adrenoleukodystrophy"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-07-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-23",
            "studyFirstSubmitQcDate": "2023-04-05",
            "studyFirstPostDateStruct": {
                "date": "2023-04-19",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-12",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-13",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Minoryx Therapeutics, S.L.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy."
        },
        "conditionsModule": {
            "conditions": [
                "Cerebral Adrenoleukodystrophy (cALD)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Leriglitazone",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Leriglitazone Treatment",
                    "interventionNames": [
                        "Drug: Leriglitazone"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Leriglitazone",
                    "description": "Leriglitazone at a strength of 15 mg/ml. Once-daily dosing at an initial volume of 10 ml",
                    "armGroupLabels": [
                        "Leriglitazone"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo will match the study drug visually and by taste",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "The primary endpoint will be the time to death or the subject becoming bedridden with a requirement for permanent ventilatory support, wichever comes earlier, in subjects treated with leriglitazone compared to placebo.",
                    "description": "The primary endpoint will be the time to death or the subject becoming bedridden with a requirement for permanent ventilatory support, wichever comes earlier, in subjects treated with leriglitazone compared to placebo.",
                    "timeFrame": "Interim analysis 1 (at 18 months of treatment)"
                },
                {
                    "measure": "The primary endpoint will be the time to death or the subject becoming bedridden with a requirement for permanent ventilatory support, wichever comes earlier, in subjects treated with leriglitazone compared to placebo.",
                    "description": "The primary endpoint will be the time to death or the subject becoming bedridden with a requirement for permanent ventilatory support, wichever comes earlier, in subjects treated with leriglitazone compared to placebo.",
                    "timeFrame": "Interim analysis 2 (at 27 months of treatment)"
                },
                {
                    "measure": "The primary endpoint will be the time to death or the subject becoming bedridden with a requirement for permanent ventilatory support, wichever comes earlier, in subjects treated with leriglitazone compared to placebo.",
                    "description": "The primary endpoint will be the time to death or the subject becoming bedridden with a requirement for permanent ventilatory support, wichever comes earlier, in subjects treated with leriglitazone compared to placebo.",
                    "timeFrame": "Final analysis (at 36 months of treatment)"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change from Baseline in Loes Score.",
                    "description": "Change from Baseline in Loes Score. Loes Score Minimum = 0 Maximum =34 0 better outcome (healthy) 34 worst osutcome",
                    "timeFrame": "Interim analysis 1 (at 18 months of treatment)"
                },
                {
                    "measure": "Change from Baseline in Loes Score",
                    "description": "Change from Baseline in Loes Score. Loes Score Minimum = 0 Maximum =34 0 better outcome (healthy) 34 worst osutcome",
                    "timeFrame": "Interim analysis 2 (at 27 months of treatment)"
                },
                {
                    "measure": "Change from Baseline in Loes Score",
                    "description": "Change from Baseline in Loes Score. Loes Score Minimum = 0 Maximum =34 0 better outcome (healthy) 34 worst osutcome",
                    "timeFrame": "Final analysis (at 36 months of treatment)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Key Inclusion Criteria:\n\n* Subject is male and aged \u226518 years.\n* Subject has progressive cALD, defined as GdE+ brain lesions.\n* Subjects for whom HSCT is not recommended by the investigator or subject is not willing to undergo HSCT.\n* Subject has a Loes score \u22650.5 and \u226412 at Screening.\n* Subject does not have major functional disability in the Major Functional Disabilities-Neurological Function Score (MFD-NFS), except for \"wheelchair bound\" or \"total incontinence\", which will be allowed as these are considered expected symptoms of AMN in the time course of the disease\n* Subject does not have major cognitive impairment which would impair his ability to take part in the study as determined by the investigator at screening.\n\nKey Exclusion Criteria:\n\n* Subject who had previous bone marrow transplantation (HSCT) or treatment with ex-vivo gene therapy (eli-Cel).\n* Subject has known type 1 or type 2 diabetes.\n* Subject has known hypersensitivity or intolerance to pioglitazone or any other thiazolidinedione.\n* Subject is taking or has taken honokiol, pioglitazone, or other thiazolidinediones within 3 months prior to Screening.\n* Subject with current participation in another interventional clinical study or within 1 month prior to Screening.\n* Subject with other medical, neuropsychiatric or social conditions that, in the opinion of the investigator, are likely to adversely affect the risk-benefit of study participation, interfere with study compliance, or confound the study results.",
            "healthyVolunteers": false,
            "sex": "MALE",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "locations": [
                {
                    "facility": "Stanford University Medical Center",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94304-5978",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jacinda Sampson",
                            "role": "CONTACT",
                            "phone": "650-723-0993",
                            "email": "jacindas@stanford.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                },
                {
                    "facility": "Neuro Medicine Hospital / UF Health",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32608",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Hans Shuhaiber",
                            "role": "CONTACT",
                            "phone": "312-286-1059",
                            "email": "hshuhaiber@ufl.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                },
                {
                    "facility": "Kennedy Krieger Institute",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21205",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ali Fatemi",
                            "role": "CONTACT",
                            "phone": "443-923-2769",
                            "email": "fatemi@kennedykrieger.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Reza Seyedsadjadi",
                            "role": "CONTACT",
                            "phone": "919-280-5582",
                            "email": "rseyedsadjadi@mgh.harvard.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Minnesota",
                    "status": "RECRUITING",
                    "city": "Minnesota",
                    "state": "Minnesota",
                    "zip": "55455",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Troy Lund",
                            "role": "CONTACT",
                            "phone": "612-625-6687",
                            "email": "lundx072@umn.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.09385,
                        "lon": -91.7496
                    }
                },
                {
                    "facility": "Health University of Utah",
                    "status": "RECRUITING",
                    "city": "Salt Lake City",
                    "state": "Utah",
                    "zip": "84112",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Joshua Bonksowsky",
                            "role": "CONTACT",
                            "phone": "801-213-3599",
                            "email": "joshua.bonkowsky@hsc.utah.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.76078,
                        "lon": -111.89105
                    }
                },
                {
                    "facility": "Hospital Austral",
                    "status": "RECRUITING",
                    "city": "Buenos Aires",
                    "country": "Argentina",
                    "contacts": [
                        {
                            "name": "Hernan Amartino",
                            "role": "CONTACT",
                            "phone": "+542304387458",
                            "email": "carolina.acevedo@resolutioncrs.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": -34.61315,
                        "lon": -58.37723
                    }
                },
                {
                    "facility": "Federal University of Sao Paulo",
                    "status": "RECRUITING",
                    "city": "S\u00e3o Paulo",
                    "country": "Brazil",
                    "contacts": [
                        {
                            "name": "Paulo Sgobbi",
                            "role": "CONTACT",
                            "phone": "+55(11)913323742",
                            "email": "pvsgobbi@gmail.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": -23.5475,
                        "lon": -46.63611
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000326",
                    "term": "Adrenoleukodystrophy"
                }
            ],
            "ancestors": [
                {
                    "id": "D000020739",
                    "term": "Brain Diseases, Metabolic, Inborn"
                },
                {
                    "id": "D000001928",
                    "term": "Brain Diseases, Metabolic"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000020279",
                    "term": "Hereditary Central Nervous System Demyelinating Diseases"
                },
                {
                    "id": "D000056784",
                    "term": "Leukoencephalopathies"
                },
                {
                    "id": "D000003711",
                    "term": "Demyelinating Diseases"
                },
                {
                    "id": "D000038901",
                    "term": "Mental Retardation, X-Linked"
                },
                {
                    "id": "D000008607",
                    "term": "Intellectual Disability"
                },
                {
                    "id": "D000019954",
                    "term": "Neurobehavioral Manifestations"
                },
                {
                    "id": "D000009461",
                    "term": "Neurologic Manifestations"
                },
                {
                    "id": "D000040181",
                    "term": "Genetic Diseases, X-Linked"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000020271",
                    "term": "Heredodegenerative Disorders, Nervous System"
                },
                {
                    "id": "D000008661",
                    "term": "Metabolism, Inborn Errors"
                },
                {
                    "id": "D000018901",
                    "term": "Peroxisomal Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000000309",
                    "term": "Adrenal Insufficiency"
                },
                {
                    "id": "D000000307",
                    "term": "Adrenal Gland Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3677",
                    "name": "Adrenoleukodystrophy",
                    "asFound": "Adrenoleukodystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5205",
                    "name": "Brain Diseases, Metabolic",
                    "relevance": "LOW"
                },
                {
                    "id": "M22498",
                    "name": "Brain Diseases, Metabolic, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6909",
                    "name": "Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M22099",
                    "name": "Hereditary Central Nervous System Demyelinating Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M28591",
                    "name": "Leukoencephalopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M11589",
                    "name": "Intellectual Disability",
                    "relevance": "LOW"
                },
                {
                    "id": "M24774",
                    "name": "Mental Retardation, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M21826",
                    "name": "Neurobehavioral Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M12404",
                    "name": "Neurologic Manifestations",
                    "relevance": "LOW"
                },
                {
                    "id": "M24877",
                    "name": "Genetic Diseases, X-Linked",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M22092",
                    "name": "Heredodegenerative Disorders, Nervous System",
                    "relevance": "LOW"
                },
                {
                    "id": "M11641",
                    "name": "Metabolism, Inborn Errors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20939",
                    "name": "Peroxisomal Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3661",
                    "name": "Adrenal Insufficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M3659",
                    "name": "Adrenal Gland Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T218",
                    "name": "Adrenomyeloneuropathy",
                    "asFound": "Adrenoleukodystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T5954",
                    "name": "X-linked Adrenoleukodystrophy",
                    "asFound": "Adrenoleukodystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "T4503",
                    "name": "Peroxisomal Biogenesis Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}